These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 9590253

  • 1. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y.
    J Immunol; 1998 May 15; 160(10):5037-44. PubMed ID: 9590253
    [Abstract] [Full Text] [Related]

  • 2. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K.
    J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152
    [Abstract] [Full Text] [Related]

  • 3. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing.
    Yanagawa Y, Masubuchi Y, Chiba K.
    Immunology; 1998 Dec 01; 95(4):591-4. PubMed ID: 9893050
    [Abstract] [Full Text] [Related]

  • 4. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T, Kiyochi H, Honda K, Kobayashi N.
    Transpl Immunol; 2004 Nov 01; 13(3):161-8. PubMed ID: 15381198
    [Abstract] [Full Text] [Related]

  • 5. FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.
    Chiba K, Yanagawa Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y.
    Transplant Proc; 1999 Nov 01; 31(1-2):1230-3. PubMed ID: 10083549
    [No Abstract] [Full Text] [Related]

  • 6. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 7. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY, Tokita D, Wang Z, Wang HC, Zhan J, Brinkmann V, Thomson AW.
    Transpl Immunol; 2008 Nov 18; 20(1-2):88-94. PubMed ID: 18694829
    [Abstract] [Full Text] [Related]

  • 8. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T, Hasegawa T, Nakai H, Azuma T, Usui N, Sasaki T, Okada A.
    Transplantation; 2003 May 15; 75(9):1469-74. PubMed ID: 12792499
    [Abstract] [Full Text] [Related]

  • 9. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K.
    Pharmacol Ther; 2005 Dec 15; 108(3):308-19. PubMed ID: 15951022
    [Abstract] [Full Text] [Related]

  • 10. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR, Silva LB, Cury PM, Burdmann EA, Bueno V.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1911-8. PubMed ID: 17161344
    [Abstract] [Full Text] [Related]

  • 11. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS, Nogueira-Martins MF, Silva HT, Pestana JO, Bueno V.
    Transplant Proc; 2004 May 20; 36(4):1015-7. PubMed ID: 15194353
    [Abstract] [Full Text] [Related]

  • 12. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
    Liu L, Wang C, He X, Shang W, Bi Y, Wang D.
    Microsurgery; 2007 May 20; 27(4):300-4. PubMed ID: 17477424
    [Abstract] [Full Text] [Related]

  • 13. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K, Matsuyuki H, Maeda Y, Sugahara K.
    Cell Mol Immunol; 2006 Feb 20; 3(1):11-9. PubMed ID: 16549044
    [Abstract] [Full Text] [Related]

  • 14. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 15. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH, Milekhin V, Zhang H, Huang HZ.
    Acta Pharmacol Sin; 2003 Sep 15; 24(9):847-52. PubMed ID: 12956930
    [Abstract] [Full Text] [Related]

  • 16. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA, Gibb DR, Picard F, Brinkmann V, Straume M, Ley K.
    Eur J Immunol; 2005 Dec 15; 35(12):3570-80. PubMed ID: 16285007
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipients.
    Böhler T, Schütz M, Budde K, Neumayer HH, Waiser J.
    Int Immunopharmacol; 2007 Jan 15; 7(1):88-95. PubMed ID: 17161821
    [Abstract] [Full Text] [Related]

  • 18. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.
    Chiba K, Hoshino Y, Suzuki C, Masubuchi Y, Yanagawa Y, Ohtsuki M, Sasaki S, Fujita T.
    Transplant Proc; 1996 Apr 15; 28(2):1056-9. PubMed ID: 8623225
    [No Abstract] [Full Text] [Related]

  • 19. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G, Domínguez-Perles R, Brinkmann V, Del Rio ML, Muñoz-Luna A, Ramírez-Romero P, Parrilla-Paricio P, Rodríguez-Barbosa JI.
    Transplant Proc; 2005 Nov 15; 37(9):4124-6. PubMed ID: 16386642
    [Abstract] [Full Text] [Related]

  • 20. Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.
    Lopes CT, Gallo AP, Palma PV, Cury PM, Bueno V.
    Transplant Proc; 2008 Apr 15; 40(3):856-60. PubMed ID: 18455036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.